Vitamin C: uses, evidence, dosing and safety

Vitamin C has been the subject of the longest-running argument in nutrition, and after sixty years the honest answer is still unsatisfying.

It does not stop you catching colds. It may shorten one slightly. And almost everything else it is sold for sits at low or very low certainty.

What vitamin C is

Vitamin C is a water-soluble vitamin, and it is needed for normal growth and development.

The water-soluble part matters more than it sounds. Water-soluble vitamins dissolve in water, and leftover amounts of the vitamin leave the body through the urine. There is no store to fill: although the body keeps a small reserve of these vitamins, they have to be taken regularly.

That is the physiological basis for the joke about expensive urine, and it is broadly accurate. Absorption falls sharply as the dose rises, and what is not used is excreted.

How vitamin C works

Its best-defined job is building collagen, the protein scaffold of skin, blood vessels, gums, bone and connective tissue. Vitamin C is required by the enzymes that stabilize collagen, which is why deficiency shows up as bleeding gums, poor wound healing and fragile vessels.

Separately it acts as an antioxidant in the watery parts of cells and helps regenerate vitamin E.

That antioxidant role is the one behind most of the claims below, and it is also the reason to be careful. A compound that mops up reactive molecules in a test tube does not reliably do anything useful in a person, and this page is largely a record of that gap.

What the evidence says about vitamin C and the common cold

The famous question, and the answer has two halves that get conflated constantly.

Regular supplementation does not stop you catching colds in the general population. A 2025 review states it directly and then reports what does hold: evidence that vitamin C reduces the severity and duration of the common cold.

So the split is prevention versus duration. Taking it every day may make a cold that arrives slightly shorter and milder. Starting it once symptoms appear, which is what most people do, has much weaker support.

The review’s practical suggestion is worth quoting exactly, because it is often reported as an endorsement. Given the good safety profile and low cost, it says, it is not unreasonable for patients to test whether therapeutic vitamin C supplementation at a dose of 6-8 g/day is beneficial at the individual level.

That is a suggestion to run your own experiment, at a dose 60 to 80 times the daily requirement. It is not a finding.

What the evidence says about vitamin C and pneumonia

Where the cold question gets serious, and Cochrane’s answer is a clean statement of not knowing.

Due to the small number of included studies and very low certainty of the existing evidence, we are uncertain of the effect of vitamin C supplementation for the prevention and treatment of pneumonia.

Even the more basic questions were unanswerable. We are uncertain of the effect of vitamin C supplementation on duration of illness and hospitalization, and none of the included studies reported other primary or secondary outcomes.

The 2025 review adds a note of encouragement without overstating it: four trials reported a treatment benefit for pneumonia patients, although the findings encourage further research rather than providing firm evidence of efficacy.

What the evidence says about vitamin C and blood pressure

One of the better numbers on this page, wrapped in the usual caution.

A 2026 umbrella review found that vitamin C supplementation may reduce SBP by approximately 3.7 mmHg. SBP is systolic blood pressure, the upper reading.

The lower reading, DBP or diastolic blood pressure, did not move across the board. Though DBP did not decrease overall, a clinically important reduction was observed in patients with diabetes of about 2.3 points.

Nearly four points off the top number is not trivial; blood pressure drugs are approved on less. The catch is stated by the reviewers: the low certainty of evidence highlights the necessity for larger, long-term randomized trials to definitively confirm its efficacy.

What the evidence says about vitamin C and heart disease

An umbrella review that spends most of its length explaining why it cannot answer the question.

Its own summary emphasizes the weakness of the current evidence base about effects of vitamin C supplementation on markers of CVD risk. CVD is cardiovascular disease.

What it does offer is a description of who might respond, and it is the pattern this whole site keeps finding. There is limited evidence that some population subgroups, older people, the obese, those with lower vitamin C status at baseline, and those at higher CVD risk, may be more responsive to vitamin C supplementation.

Lower status at baseline is the operative phrase. The people who respond are the people who were short.

The reviewers ask for trials designed around that: future studies should implement a selective recruitment strategy rather than recruiting whoever is available and diluting the effect to nothing.

What the evidence says about vitamin C and blood sugar

Small, uneven, and mostly not about blood sugar at all.

A 2026 review of vitamin C, vitamin E and the two combined found that their effects on glycemic control, diastolic blood pressure, and blood lipids other than HDL were comparable, meaning no meaningful difference between them or against control.

What did move was narrow: an increase in high-density-lipoprotein (HDL) levels was noted exclusively with the combined vitamin C + E supplementation. HDL is the protective cholesterol.

One marker, in one combination, out of a panel. That is the shape of a chance finding as much as a real one.

What the evidence says about vitamin C in cancer care

More promising than most of this page, and it belongs in a clinic rather than a shopping basket.

A 2026 review found vitamin C associated with reduced inflammation, oxidative stress, and radiotherapy-related side effects, as well as improved quality of life.

On survival, it splits by cancer type. Benefits appeared in blood cancers, while evidence remains inconsistent in solid tumors.

Its conclusion is modest and useful: vitamin C may enhance tolerability and patient-reported outcomes in cancer therapy, with a call for larger, well-designed trials.

Two cautions. This literature largely concerns high-dose intravenous vitamin C, which reaches concentrations oral tablets cannot. And anyone in treatment needs to raise antioxidants with their oncology team, because some cancer therapies work by causing oxidative damage.

What the evidence says about vitamin C in pregnancy

A clean negative, and worth having because vitamin C appears in some prenatal regimens.

A 2025 review found vitamin C supplementation alone or in combination with vitamin E does not significantly prevent preterm birth or improve related neonatal outcomes.

The list of things that did not change is comprehensive. No significant differences were observed for neonatal death, admission to intensive care, early rupture of membranes, or birth weight.

There was one signal in the wrong direction, small and uncertain: a slight decrease in gestational age was observed.

What the evidence says about vitamin C and post-exercise recovery

Popular among athletes, and the recent evidence does not support it.

A 2026 review found vitamin C supplementation does not appear to consistently modify post-exercise inflammatory or oxidative stress biomarkers.

The reviewers are unusually direct about the state of the evidence: it is based on a very limited number of small randomized trials, with low to very low certainty, substantial methodological limitations, and imprecision, and should be considered hypothesis-generating.

There is also a theoretical concern this literature keeps circling. Exercise adaptation is partly driven by the oxidative stress exercise produces, so blunting it with antioxidants might interfere with training gains. Nothing here settles that either way.

What the evidence says about vitamin C and nerve pain after surgery

A narrow use with a genuinely instructive result, because the paper contradicts itself.

Complex regional pain syndrome, abbreviated CRPS, is a severe, persistent pain condition that sometimes follows a limb injury or operation. A 2024 review examined whether vitamin C prevents it.

The finding: VC supplementation have effect on reducing CRPS-I post-limb surgery - VC being vitamin C and CRPS-I the pain syndrome - but the same sentence records that the pooled effect size did not clear the threshold.

Then the conclusion states the positive half alone: the results of our study showed the positive effect of VC supplementation in reducing the prevalence of CRPS-I after limb surgery.

Those two sentences are in the same paper. The reviewers also report that publication bias was detected, indicating asymmetry in the funnel plot, which means the smaller negative studies are probably missing.

Vitamin C for this indication appears in some surgical guidance. On this evidence it is a plausible, cheap, unproven addition, and the gap between a paper’s results and its conclusion is the reason to read past the abstract.

Myths about vitamin C, and what the evidence says

“Vitamin C prevents colds.” Not in the general population. What the evidence supports is a modest reduction in severity and duration for people already taking it regularly.

“Take a big dose at the first sniffle.” That is the version with the weakest support. The trials showing anything used continuous supplementation.

“More is better.” Absorption falls as the dose rises and the excess is excreted. The one reliable effect of very high doses is diarrhea.

“It is a proven antioxidant, so it protects your heart.” The umbrella review of cardiovascular markers describes its own evidence base as weak, with responders limited to those who were low to begin with.

“Vitamin C is completely harmless.” Mostly, but it is metabolized to oxalate, so it raises kidney stone risk in susceptible people, and high doses interfere with some blood tests.

“Nobody gets scurvy any more.” MedlinePlus notes deficiency still occurs, and mainly affects older, malnourished adults.

Dosing and forms of vitamin C

The daily requirement is in the tens of milligrams, comfortably met by ordinary food: citrus, peppers, broccoli, strawberries, potatoes and tomatoes.

The doses used in the cold trials are in a different category, at several grams a day, and they are what the 2025 review means by therapeutic rather than nutritional use.

Forms are largely a marketing question. Buffered ascorbate is gentler on the stomach; liposomal preparations claim higher absorption at considerably higher cost, without outcome trials to support the claim; and “natural” rose hip vitamin C is chemically identical to the synthetic kind.

Because the body holds only a small reserve, splitting a dose is more useful than taking it all at once.

Safety, side effects and who should be careful

At ordinary intakes vitamin C is about as safe as a supplement gets. Excess is excreted, and the practical ceiling is gastrointestinal: diarrhea, cramping and nausea at high grams.

The exception worth knowing is oxalate. Vitamin C is converted to oxalate, the main component of the commonest kidney stones, so anyone with a stone history, kidney disease or on dialysis should not take high doses without advice.

People with hemochromatosis or another iron-overload condition should also be careful, because vitamin C increases iron absorption, which is helpful for most people and unhelpful for them.

High-dose supplements can produce false readings on some home glucose meters and on stool blood tests, which occasionally matters more than the supplement does.

Interactions

The main interaction is one people use deliberately: vitamin C substantially improves absorption of plant iron, which is why it is recommended alongside iron supplements and iron-rich meals for vegetarians.

There has been a long-running question about whether antioxidant supplements interfere with chemotherapy and radiotherapy, which work partly by oxidative damage. It is unresolved, and it is the reason cancer treatment is a doctor’s conversation rather than a self-directed one.

Very high doses may affect some medications’ excretion and can alter warfarin control, so anyone on regular medication should mention gram-level doses to a pharmacist.

Bottom line on vitamin C

Vitamin C is essential, deficiency is unpleasant and still exists, and the supplement is one of the safest things in the aisle.

It is also one of the least impressive. It does not prevent colds. Cochrane cannot say whether it does anything for pneumonia. Its cardiovascular evidence base is described as weak by the people who reviewed it, and in pregnancy it did nothing at all.

Two findings are worth keeping. Blood pressure fell by nearly four points, at low certainty, which is a real number waiting on a better trial. And across several sections the responders were the same people: those who were low to begin with.

For everyone else, an orange is the correct dose and it costs less.